Medicinova (MNOV) Change in Receivables (2014 - 2021)

Medicinova's (MNOV) quarterly Change in Receivables came in at $4.0 million in Q1 2021, up 166.57% on a QoQ basis from -$6.0 million in Q1 2014.

Medicinova (MNOV) Change in Receivables (2014 - 2021) Analysis & Trends

Medicinova (MNOV) has 2 years of Change in Receivables data on file, last reported at $4.0 million in Q1 2021.

On a quarterly basis, Change in Receivables changed N/A year-over-year to $4.0 million in Q1 2021; TTM through Mar 2021 was $4.0 million, a N/A change from a year earlier, with the FY2014 full-year figure at -$6.0 million, down 200.0% from the prior year.
Change in Receivables for Q1 2021 stood at $4.0 million, up from -$6.0 million in the prior quarter.
Over the last five years, Change in Receivables for MNOV reached as high as $4.0 million in Q1 2021 and fell as low as $4.0 million in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	75.30 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	2.84 Mn
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-39.80 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-1.20 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Medicinova	64.48 Mn	64.48 Mn	4,754.00	-

Download Data